PeptideStack
5.2kquestions
20kanswers
220users

How does HJ compare to Zhuhai Kerui Biotechnology on documentation quality?

Asked 23 Dec 2024Modified 15 months agoViewed 11k times
22

Conditions: HJ · Zhuhai Kerui Biotechnology.

These are treated as interchangeable and I do not think they are.

If both are acceptable I would like to know that, so I can stop thinking about it.

Is there a defensible reason to prefer one, or is this a coin flip?

vendor-comparison
vendor-comparison

Side-by-side comparison of suppliers on measurable axes - independently confirmed purity and content, lead time, cold-chain handling,…

388 questions
coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

771 questions
vendor-vetting
vendor-vetting

Evaluating a supplier on evidence rather than reputation: testing history across batches, whether certificates are batch-specific, how failures…

454 questions
shareeditfollowflag
TM
askedtwo_two_micron9.3k1623 Dec 2024
6Can you say what you are optimising for? Cost and confidence pull in opposite directions. – Dr_Ilse_Vandenberg 18 days ago
7Voting to keep this open — it is more specific than it first looks. – charge_state_3 2 months ago
add a comment

5 Answers

Accepted answer first, then by votes
109

Accepted answer

This is the question where methodology matters more than the conclusion.

Sample size matters. One order each is an anecdote about six vials; three orders each over a year is the beginning of a comparison.

Certificate red flags and what each implies

ObservationImplicationHow to check
Lot number not on the vialCertificate cannot be tied to your materialPhotograph vial and certificate together
No method sectionThe number is not reproducibleRequest column, gradient, wavelength
Purity to two decimals, no chromatogramFalse precisionRequest the trace
Test date before manufacture dateCertificate belongs to a different lotCompare dates
Identical figures across lotsOne certificate reusedCompare two lots side by side
“Sterile filtered” with no sterility testProcess claim substituted for a resultAsk for the sterility report

Content is the more discriminating measurement than purity for supplier comparison, because purity clusters tightly among competent suppliers and content does not.

Gradient slope, column chemistry and detection wavelength all affect the reported purity figure, which is why the method section is the part that makes results comparable.

Nothing here is medical advice, and research-use compounds are not approved for human use.

Compare content, not purity. Purity clusters and content does not.

shareimprove this answerflag
KA
answered · acceptedkwn_analytical147k35817 Apr 2025
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
47

Ratings on this site are ours alone and are deliberately not reconciled with anyone else's.

Cost per milligram of actual peptide is the honest price comparison, which means dividing by measured content rather than by label claim.

The relevant detail is that lead time and lane behaviour are supplier properties too and are easier to compare than analytical ones, because they need no laboratory at all.

Inter-laboratory spread on identical peptide material is routinely half a per cent to a per cent by RP-HPLC, which is the noise floor for any cross-laboratory comparison.

One laboratory, one method, one submission. Otherwise it is not a comparison.

shareimprove this answerflag
DO
answeredDr_Lena_Ostrowska38k2714 Mar 2025
7Adding a vote because this deserves more of them. – e_dziedzic 7 months ago
6I would add a line about writing the accept threshold down first. It is the step everyone skips. – Dr_Jonas_Halvorsen 5 months ago
add a comment
38

Answering this needs the axis. A supplier that is best on paperwork and a supplier that is best on price are both correct answers to different questions.

Compare documentation on a fixed checklist rather than by impression: lot specificity, method section, chromatogram availability, quantified content, water and counter-ion figures, and whether the code is on the vial.

Put another way, publish the method with the result. A comparison without the laboratory named and the submission dates given is not reproducible by anyone.

The ratings on this site are a community opinion average on a ten-point scale and are not reconciled with any other community's figures.

Name the laboratory and the dates or the comparison cannot be reproduced.

shareimprove this answerflag
WO
answeredw_okoye43k13726 Mar 2025
Small correction: carriage amortises across the order, which changes small-order economics entirely. – mz_4113 1 days ago
add a comment
3

Concretely, a single member running three suppliers on one method is worth more than thirty members running one supplier each.

Submitting to different laboratories introduces a method difference that commonly exceeds the supplier difference. Gradient slope alone can move a reported purity figure by a per cent in either direction.

Comparisons drawn from different laboratories at different times are weaker evidence than most people treat them as.

Price per milligram of measured peptide, not per milligram of label claim.

edited 4 Mar 2025 by a_lindgren — added the method parameters

shareimprove this answerflag
AL
answereda_lindgren58k24820 Feb 2025
2

Start by asking what you are optimising for, because cost per milligram, documentation depth and lead time do not have a common winner.

To compare properly: order the same compound at the same nominal strength from each supplier, submit all samples to the same laboratory in the same submission if possible, and ask for the same test set on each.

Content assay results across the published datasets vary considerably more between suppliers than purity does, which makes content the more discriminating axis.

No supplier on this site pays for its position, and the storefront links are marked nofollow and sponsored.

Use a fixed documentation checklist rather than an impression.

shareimprove this answerflag
TM
answeredtobias_maartens171k3586 Apr 2025

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.